CN105823764B - Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application - Google Patents

Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application Download PDF

Info

Publication number
CN105823764B
CN105823764B CN201610153193.3A CN201610153193A CN105823764B CN 105823764 B CN105823764 B CN 105823764B CN 201610153193 A CN201610153193 A CN 201610153193A CN 105823764 B CN105823764 B CN 105823764B
Authority
CN
China
Prior art keywords
graphene oxide
cup
aromatic hydrocarbons
adenine derivative
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201610153193.3A
Other languages
Chinese (zh)
Other versions
CN105823764A (en
Inventor
王丽
赵玉霞
石硕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongji University
Original Assignee
Tongji University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongji University filed Critical Tongji University
Priority to CN201610153193.3A priority Critical patent/CN105823764B/en
Publication of CN105823764A publication Critical patent/CN105823764A/en
Application granted granted Critical
Publication of CN105823764B publication Critical patent/CN105823764B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application, which is keyed by amide with cup [4] aromatic hydrocarbons adenine derivative by graphene oxide and is formed;Preparation method includes: that graphene oxide is carried out chloride by (1);(2) excessive cup [4] aromatic hydrocarbons adenine derivative is dissolved with organic solvent, it is added under the graphene oxide powder room temperature of chloride and stirs 6~96h, obtain black particle suspension, centrifuge separation, with saturated common salt water washing, distilled water is then added and is centrifuged, dries, obtain black powder, as cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound;The compound can be applied in terms of the identification of tetra- serobila of oncogene promoter region G-, combination or stabilization.Compared with prior art, preparation is simple by the present invention, can provide the new selection scheme detected by biological macrocycle molecule for tetra- serobila of G-.

Description

Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and preparation method thereof and Using
Technical field
The present invention relates to a kind of Calixarene Derivatives composite materials, derivative more particularly, to a kind of cup [4] aromatic hydrocarbons adenine Object-graphene oxide composite material and its preparation method and application.
Background technique
With the development of the society, huge variation, global warming, ozone layer has occurred in the living environment of mankind nowadays The various pollution problems such as cavity, bio-diversity reduction, acid rain sprawling, sharp reduction of the forests and desertification of land, it is following each Kind disease increases, and cancer is to seriously endanger one of the principal disease of human health.Various anticancer drugs increase therewith, therefore seek Low toxicity, the efficient, anticancer drug with anticancer activity are mankind nowadays urgent problems to be solved.
Promoter is that one section of important genetic region is being lost positioned at the section of DNA sequence of gene 5 ' end upstream regulatory region It passes and refers to one section of DNA sequence dna that gene can be made to be transcribed on learning.Promoter can determine the expression of gene, that is, can determine that Which proteinoid cell produces.If promoter region gene makes a variation, the expression that gene controls will be seriously affected, it is this Variation is common in malignant tumour.Therefore inhibiting the research of the expression of oncogene becomes anticancer drug action method.In document Report various metal complexs largely to detect tetra- serobila of oncogene promoter G-, but with this stereochemical structure of calixarenes Macrocyclic compound is not reported also to detect the article of tetra- serobila of G-.
Summary of the invention
It is an object of the present invention to overcome the above-mentioned drawbacks of the prior art and provide a kind of oncogene promoters G- tetra- serobila in area has cup [4] aromatic hydrocarbons adenine derivative-graphene oxide of recognition reaction, combination and stabilization multiple Condensation material, preparation is simple for the compound, provides the new selection detected by biological macrocycle molecule for tetra- serobila of G- Scheme.
The purpose of the present invention can be achieved through the following technical solutions:
A kind of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound, the compound is by graphene oxide and cup [4] aromatic hydrocarbons adenine derivative is keyed to be formed by amide.
Preferably, which passes through amido bond by the graphene oxide and cup [4] aromatic hydrocarbons adenine derivative of chloride Connection is formed.
The amido bond by aromatic hydrocarbons adenine derivative-NH2- C (O) Cl base of base and the graphene oxide of chloride Amidation process occurs to be formed.
The chemical formula of described cup [4] the aromatic hydrocarbons adenine derivative is C55H70O4N5Br, structural formula are as follows:
Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound preparation method, comprising the following steps:
(1) graphene oxide is subjected to chloride, obtains the graphene oxide powder of chloride;
(2) excessive cup [4] aromatic hydrocarbons adenine derivative is dissolved with organic solvent, the graphene oxide powder of chloride is added 6~96h is stirred under last room temperature, obtains black particle suspension, is centrifugated, with saturated common salt water washing, is then dried, obtain Black powder, as cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound.
Organic solvent in step (2) is DMF.
Preferably, the stirring at normal temperature time in step (2) is 36h.
It is added distilled water to pH=7 with saturated common salt water washing in step (2) and is centrifuged, so that chloride Graphene oxide powder surface it is clean.
Cup [4] the aromatic hydrocarbons adenine derivative being added in step (2) should be excessive, so that cup [4] aromatic hydrocarbons adenine is derivative Object is connected on graphene oxide as far as possible, because when calixarenes amount is few, cup [4] aromatic hydrocarbons adenine for being connect on graphene oxide Comparatively derivative will lack, cannot play collaboration of the two in terms of the identification of tetra- serobila of G-, combination or stabilization well Effect.
Step adds graphene oxide into the mixed solution of chlorinating agent and auxiliary agent in (1), ultrasonic by graphene oxide powder It is broken and be uniformly dispersed, 12~96h is reacted under the conditions of 60~80 DEG C and carries out chloride, is centrifuged repeatedly washing with tetrahydrofuran, it is cold Freeze the graphene oxide powder for being dried to obtain chloride.
Preferably, the acyl chloride reaction in step (1) reacts 48h under the conditions of 70 DEG C.
Chlorinating agent described in step (1) is thionyl chloride, and the auxiliary agent is DMF.
DMF in step (1) as auxiliary agent plays the role of catalyst and solubilizer.
Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound tetra- serobila of oncogene promoter region G- identification, In conjunction with or stablize aspect application.
The oncogene promoter is the oncogene DNA sequence dna of the mankind.
Graphene oxide has good surface-active, and a large amount of π-π binding sites and hydrogen bond that surface can provide, warp After crossing chloride processing, it can be good at generating with cup [4] aromatic hydrocarbons adenine derivative and react, form compound.Calixarenes is A kind of good molecular receptor, but itself to DNA or base there is no specific recognition capability, cannot be directly used to DNA Identification, therefore adenine is connected on calixarenes, so that calixarenes has the recognition capability to DNA, so calixarenes-gland is fast Purine derivative has the recognition capability to tetra- serobila DNA of G-, but water-soluble bad.Although there is a large amount of π-on graphene oxide surface π binding site and hydrogen bond, but its surface can not adsorb tetra- serobila of G- well, and since graphene oxide graphene oxide has There are the specific surface area of super large, a large amount of hydrophilic functional groups in surface, a large amount of hydrophilic functional groups have water solubility well, so will The selection that cup [4] aromatic hydrocarbons adenine derivative can both play cup [4] aromatic hydrocarbons adenine derivative in conjunction with graphene oxide is known Other performance can play the good water-soluble and bio-compatibility of graphene oxide again.But carboxyl and cup above graphene oxide [4] combination of amino contained by aromatic hydrocarbons adenine derivative condensing agent, and reaction condition is difficult to control, so being difficult directly to connect It to together, first passes through graphene oxide chloride, amidation process then is occurring with amino, reaction condition is mild, work Skill is simple, and is easy to for the two being connected to together.
Compound of the invention have concurrently Calixarene Derivatives pair specific identification ability and graphene oxide it is excellent Bio-compatibility achievees the purpose that accurate measurements to improve the sensitivity in tetra- serobila detection process of G-.This patent design Synthesis combines cup [4] aromatic hydrocarbons adenine derivative-graphene oxide, this composite material shows the detection to tetra- serobila of G- Performance.During fluorescence sense, introducing this composite material of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide can be incited somebody to action Its unique excellent properties is integrated into the running of sensor molecules, to improve entire Operation System.This patent is antineoplastic Object provides some theoretical foundations in the application of anti-tumor aspect.
Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound of the invention is by fluorescence experiments to oncogene G- Four serobilas have enhancement effect of fluorescence, illustrate that with tetra- serobila of oncogene promoter region G- recognition reaction can occur for the composite material.It is logical CD spectrum experiment is crossed, finds being continuously increased with derivatives concentration, the maximum positive absorption peak of CD curve and minimal negative absorption peak are simultaneously There is no obviously deviating, illustrate that the composite material can stablize the structure of tetra- serobila of promoter region G-.Pass through PCR instrument thermostabilization Property experiment, testing the composite material is improved the melting temperature of tetra- serobila of G- of fluorescent marker, illustrates that the material can So that the structure of tetra- serobila of G- is more stable.
Compared with prior art, compound of the invention has recognition reaction to tetra- serobila of oncogene promoter region G-, combines Effect and stabilization, provide it is a kind of detected by the method for bio-sensing with biological macrocycle molecule tetra- serobila of G- newly Selection scheme.And preparation is simple for the compound, is easy to large-scale industrial production.
Detailed description of the invention
Fig. 1 is the infrared spectrogram for the compound that embodiment 1 is prepared;
Fig. 2 is the XDR figure for the compound that embodiment 1 is prepared;
Fig. 3 is the compound that is prepared of embodiment 1 in potassium ion buffer solution, is acted on tetra- serobila bcl-2DNA of G- Fluorescence spectra;
The CD that Fig. 4 is the compound that is prepared of embodiment 1 in potassium ion buffer solution, with the interaction of tetra- serobila of G- Titration figure;
The unwinding temperature that Fig. 5 is the compound that is prepared of embodiment 1 in potassium ion buffer solution, with the effect of tetra- serobila of G- Spend experimental curve diagram.
Specific embodiment
The present invention is described in detail with specific embodiment below in conjunction with the accompanying drawings.
Embodiment 1
A kind of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound (AC+GO), the compound is by graphite oxide Alkene is keyed to be formed by amide with cup [4] aromatic hydrocarbons adenine derivative.
The preparation method of the compound the following steps are included:
(1) 100mg graphene oxide is weighed, is added in the mixed solution of 20mL thionyl chloride and the DMF of 1mL, ultrasound makes It is uniformly dispersed, and is transferred in three-necked bottle after mixing under the conditions of 70 DEG C and reacts 48h, after reaction with tetrahydrofuran repeatedly from The heart washing, be freeze-dried chloride graphene oxide powder 0.085g.
(2) excessive cup [4] aromatic hydrocarbons adenine derivative is dissolved with the DMF of 50mL, step (1) resulting chloride is added Graphene oxide powder in, stir 36h at normal temperature, obtain the black particle suspension of good dispersion, be centrifugated, with full And brine It, distilled water are once centrifugated, and dry to obtain black powder product 0.076g, as cup [4] aromatic hydrocarbons adenine Derivative-graphene oxide compound (AC+GO).
Infrared figure:
AC:3404 ,-Ar-OH
2952 ,-CH3 ,-CH2
2869 ,-CH2
1643 ,-C=N
1595 ,-NH2
1360 ,-C (CH3) 3
GO:
3410 ,-OH
1714 ,-C=O
1621 ,-C=C
1220 ,-C-H
1044 ,-C-O
AC+GO:
3354 ,-N-H
3133 ,-Ar-OH
1646 ,-C=O
1410 ,-C-OH
By the infared spectrum of Fig. 1 it is found that the graphene oxide after amidation occurs in amido bond in 3354cm-1 N-H key stretching vibration absworption peak, occur the C=O absorption peak in amido bond at 1646cm-1.Thus it can tentatively demonstrate,prove Bright, calixarenes adenine derivative-graphene oxide successfully connects in surface of graphene oxide.
XRD diagram: 100 be the characteristic peak of graphene oxide;It 16.80, is that cup [4] aromatic hydrocarbons adenine is derivative at 26.80,430 Object-graphene oxide characteristic peak.
By in the XRD diagram of Fig. 2 it is found that after in conjunction with calixarenes adenine derivative, the characteristic peak of graphene oxide GO from 100 are displaced to 16.80, this is that occur near 26.80 and 430 two wide and wide caused by interlayer oxygen-containing functional group is reduced This peak of diffraction maximum is consistent substantially with the characteristic peak positions of graphene, and the above XRD result illustrates there is partial oxidation in amidation process Graphene reduction, product remains the structure of graphene oxide, while producing a part of graphene-structured again, stacks shape in a jumble At diffraction maximum.It can thus be appreciated that calixarenes obtained and graphene oxide are rather than two kinds by covalently bound product Simple mechanical mixture.
AC+GO is used to detect tetra- serobila of G-.
Tris-HCl-K buffer solution A: 10mM Tris, 100mM KCl, pH=7.0;
Preparation method: accurately weighing 1.212g Tris salt, and 7.46g KCl is completely dissolved simultaneously with 100mL triple distillation water Mixing, slowly adjusts pH value to 7.0 with the dilute hydrochloric acid diluted by triple distillation water, 1000ml volumetric flask is transferred to, with triple steamings Distilled water constant volume shakes spare after mixing.
Phosphate buffer solution B:10mM KH2PO4-K2HPO4, 100mM KCl, pH=7.0;
Preparation method: 0.174g K is weighed with electronic balance2HPO4·3H2O and 0.746gKCl, with 100mL volumetric flask and It is 100mM KCl, 10mM K that triple distillation water, which is configured to concentration,2HPO4Solution;Weigh 0.136g KH2PO4With 0.746g KCl, It is 100mM KCl, 10mM KH with above-mentioned same preparation method compound concentration2PO4Solution.Taking volume is 61.5mL K2HPO4 With 38.5mL KH2PO4Solution is mutually mixed, and the phosphate buffer solution for the PH=7 that concentration is 100mM KCl can be obtained.
The preparation (concentration 200uM) of complex solution:
The compound of 2mg is weighed with electronic balance, volume is fixed by required concentration, dissolution first is shaken with the DMF of 150uL, then It is settled to required volume with high purity water, concussion can uniformly obtain the complex solution of 200uM.
The preparation of DNA solution and the measurement of concentration:
(1) tetra- serobila DNA (bcl-2DNA) of G-
Preparation method: taking the bcl-2DNA of about 10OD, adds buffer solution A to dissolve with the volume of corresponding label, water is used after sealing Bath is heated to 90 DEG C and is kept for 10 minutes, is put into refrigerator and refrigerates 24 hours or more after being slowly cooled to room temperature, spare.
(2) fluorescent marker bcl-2DNA
Preparation method: taking the fluorescent marker bcl-2DNA of about 2OD, adds buffer solution B to dissolve with the volume of corresponding label, sealing Afterwards with heating water bath to 90 DEG C and keep 10 minutes, be put into refrigerator and refrigerate 24 hours or more after being slowly cooled to room temperature, it is spare.
One, the fluorescence titration experiment of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound
Instrument: 7000 fluophotometer of Hitachi FP;
Instrument parameter: excitation wavelength: 480nm, slit width: 10nm, voltage: 500V;
Scanning range: 500-700nm;
When experiment, taking volume is the cuvette that the compound that 10uL concentration is 200uM is added to 1990uL buffer solution A In, repeatedly it is uniformly mixed solution with the slow compressing of liquid-transfering gun, it is 100uM's that 10uL concentration is then added every time into cuvette DNA solution, with liquid-transfering gun, compressing is uniform repeatedly, and detection fluorescence rises situation.It operates, is added dropwise repeatedly until last at least 4 repeatedly The fluorescence peak of secondary titration will not change.Its result is as shown in Figure 3.
The result shows that: as shown in Figure 3, exist in TrisK buffer solution, with the continuous dropwise addition of DNA, on fluorescence peak is continuous It rises, finally reaches saturation.Illustrate that the compound and tetra- serobila of G- have recognition capability.
Two, the CD titration experiments of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound
Instrument: JASCO J-815;
Instrument parameter: scanning range: 225-350nm;
CD spectrum can effectively indicate the secondary structure of DNA.Tetra- serobila of parallel type G- occur near 270nm it is positive most There is negative maximum absorption band near 240nm in big absorption peak;Antiparallel type structure has maximum positive absorption peak in wavelength 290nm, There is negative maximum absorption band near 260nm;Mixed type has positive absorption peak near 290nm and has shoulder seam near 265nm. As a result as shown in Figure 4;
The result shows that: under the conditions of potassium ion, tetra- stranded structure of G oncogene promoter region DNA parallel type G-, and with multiple The increase of object concentration is closed, there is no transformations for the positive and negative absorption peak of CD map, it is known that derivative can stablize tetra- serobila of parallel type G-.
Three, the Study on Thermal Deformation experiment of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound
Instrument: BIORAD icycler (iQ5) PCR instrument
The thermostabilization research of tetra- serobila of G- is to carry out fluorescence resonance energy transfer technology using PCR instrument.Test compound To the melting temperature T of fluorescent label DNAmThe change of value.To reflect different composite object concentration to tetra- serobila DNA thermodynamics of G- The difference of stabilization.As a result as shown in Figure 5
The result shows that: in the presence of there is no compound, the T of tetra- serobila of G-mIt is worth smaller;With the addition and concentration of compound Increase, TmValue gradually increases.Ultimately joining complex concentration is that 7um makes tetra- serobila T of G-mValue increases 5 DEG C.In potassium buffer Lower compound has concentration dependent to the stabilization of tetra- serobila of G-, and has certain stabilizing power.
Embodiment 2
A kind of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound (AC+GO), the compound is by graphite oxide Alkene is keyed to be formed by amide with cup [4] aromatic hydrocarbons adenine derivative.
The preparation method of the compound the following steps are included:
(1) 100mg graphene oxide is weighed, is added in the mixed solution of 20mL thionyl chloride and the DMF of 1mL, ultrasound makes It is uniformly dispersed, and is transferred in three-necked bottle after mixing under the conditions of 60 DEG C and reacts 96h, after reaction with tetrahydrofuran repeatedly from The heart washing, be freeze-dried chloride graphene oxide powder.
(2) excessive cup [4] aromatic hydrocarbons adenine derivative is dissolved with the DMF of 50mL, step (1) resulting chloride is added Graphene oxide powder in, stir 96h at normal temperature, obtain the black particle suspension of good dispersion, be centrifugated, with full And brine It, distilled water are once centrifugated, and dry to obtain black powder product, as cup [4] aromatic hydrocarbons adenine derivative- Graphene oxide compound (AC+GO).
The compound has identification, combination and stabilization to tetra- serobila of oncogene promoter region G-.
Embodiment 3
The compound of the present embodiment is substantially the same manner as Example 1, the difference is that, the preparation of the compound of the present embodiment Method the following steps are included:
(1) 100mg graphene oxide is weighed, is added in the mixed solution of 20mL thionyl chloride and the DMF of 1mL, ultrasound makes It is uniformly dispersed, and is transferred in three-necked bottle after mixing under the conditions of 80 DEG C and reacts 12h, after reaction with tetrahydrofuran repeatedly from The heart washing, be freeze-dried chloride graphene oxide powder.
(2) excessive cup [4] aromatic hydrocarbons adenine derivative is dissolved with the DMF of 50mL, step (1) resulting chloride is added Graphene oxide powder in, stir 6h at normal temperature, obtain the black particle suspension of good dispersion, be centrifugated, with full And brine It, distilled water are once centrifugated, and dry to obtain black powder product, as cup [4] aromatic hydrocarbons adenine derivative- Graphene oxide compound (AC+GO).
The compound has identification, combination and stabilization to tetra- serobila of oncogene promoter region G-.Cancer described herein Gene promoter is the oncogene DNA sequence dna of the mankind.

Claims (9)

1. a kind of application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound, which is characterized in that applied Identification, combination or the stable aspect of tetra- serobila of oncogene promoter region G-, the compound is by graphene oxide and cup [4] aromatic hydrocarbons gland Purine derivative is keyed to be formed by amide.
2. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 1, feature It is, which is keyed by amide with cup [4] aromatic hydrocarbons adenine derivative by the graphene oxide of chloride and is formed.
3. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 2, feature Be, the amido bond by aromatic hydrocarbons adenine derivative-NH2- C (O) the Cl base of base and the graphene oxide of chloride hair Raw amidation process is formed.
4. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 1, feature It is, the chemical formula of the cup [4] aromatic hydrocarbons adenine derivative is C55H70O4N5Br, structural formula are as follows:
5. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 1, feature It is, preparation method includes the following steps:
(1) graphene oxide is subjected to chloride, obtains the graphene oxide powder of chloride;
(2) excessive cup [4] aromatic hydrocarbons adenine derivative is dissolved with organic solvent, the graphene oxide powder that chloride is added is normal Temperature is lower to stir 6~96h, obtains black particle suspension, is centrifugated, with saturated common salt water washing, be then added distilled water into Row centrifuge separation, drying obtain black powder, as cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound.
6. a kind of application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 5, It is characterized in that, the organic solvent in step (2) is DMF.
7. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 5, feature It is, step adds graphene oxide into the mixed solution of chlorinating agent and auxiliary agent in (1), and ultrasound crushes graphene oxide simultaneously It is uniformly dispersed, 12~96h is reacted under the conditions of 60~80 DEG C and carries out chloride, be centrifuged repeatedly washing with tetrahydrofuran, freezing is dry The dry graphene oxide powder for obtaining chloride.
8. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 7, feature It is, chlorinating agent described in step (1) is thionyl chloride, and the auxiliary agent is DMF.
9. the application of cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound according to claim 1, feature It is, the oncogene promoter is the oncogene DNA sequence dna of the mankind.
CN201610153193.3A 2016-03-17 2016-03-17 Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application Expired - Fee Related CN105823764B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610153193.3A CN105823764B (en) 2016-03-17 2016-03-17 Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610153193.3A CN105823764B (en) 2016-03-17 2016-03-17 Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application

Publications (2)

Publication Number Publication Date
CN105823764A CN105823764A (en) 2016-08-03
CN105823764B true CN105823764B (en) 2019-02-01

Family

ID=56523886

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610153193.3A Expired - Fee Related CN105823764B (en) 2016-03-17 2016-03-17 Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application

Country Status (1)

Country Link
CN (1) CN105823764B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107033176B (en) * 2017-04-20 2019-08-02 同济大学 Cup [4] aromatic hydrocarbons phenyl boronic acid derivative/multi-wall carbon nano-tube composite material preparation method and applications
CN107604465B (en) * 2017-09-19 2019-10-29 旷达纤维科技有限公司 A kind of antistatic hollow coloured polyester fiber of abnormity and preparation method thereof of high fire-retardance
CN109406470B (en) * 2018-10-26 2021-03-26 云南大学 Construction method and application of fluorescent sensor based on competitive identification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009085015A1 (en) * 2008-01-03 2009-07-09 National University Of Singapore Functionalised graphene oxide
CN101818059B (en) * 2010-03-29 2013-02-27 中国科学院合肥物质科学研究院 Method for preparing graphene oxide with high fluorescent quantum yield
CN103137975B (en) * 2011-11-30 2015-07-08 海洋王照明科技股份有限公司 Grapheme derivative material, preparation method of grapheme derivative material, and applications of grapheme derivative material
CN103524504A (en) * 2012-07-06 2014-01-22 同济大学 Guanine derivative as well as preparation method and application thereof
CN104926844B (en) * 2015-05-22 2017-07-11 同济大学 Cup [8] areneboronic acid derivative and preparation, the composite containing the derivative and application

Also Published As

Publication number Publication date
CN105823764A (en) 2016-08-03

Similar Documents

Publication Publication Date Title
Shi et al. Specific detection of integrin αvβ3 by light-up bioprobe with aggregation-induced emission characteristics
Wang et al. A novel ratiometric fluorescent probe for detection of iron ions and zinc ions based on dual-emission carbon dots
Liu et al. Turn-on fluorescence sensor for the detection of heparin based on rhodamine B-modified polyethyleneimine–graphene oxide complex
Yang et al. Turn-on fluorescence sensor for glutathione in aqueous solutions using carbon dots–MnO2 nanocomposites
CN105823764B (en) Cup [4] aromatic hydrocarbons adenine derivative-graphene oxide compound and its preparation method and application
Qian et al. Simultaneous detection of multiple DNA targets by integrating dual‐color graphene quantum dot nanoprobes and carbon nanotubes
JP6081152B2 (en) Fluorescent compounds comprising tetraphenylethene derivatives
Liu et al. A ratiometric nanoprobe for biosensing based on green fluorescent graphitic carbon nitride nanosheets as an internal reference and quenching platform
Zhang et al. Highly selective and sensitive detection of coralyne based on the binding chemistry of aptamer and graphene oxide
Zhu et al. Nitrogen-doped carbon dots-V2O5 nanobelts sensing platform for sensitive detection of ascorbic acid and alkaline phosphatase activity
Jiang et al. Fluorescence detection of protamine, heparin and heparinase II based on a novel AIE molecule with four carboxyl
Hu et al. A rapid and sensitive turn-on fluorescent probe for ascorbic acid detection based on carbon dots–MnO 2 nanocomposites
Zhao et al. Near-infrared fluorescence MOF nanoprobe for adenosine triphosphate-guided imaging in colitis
Xie et al. Label-free and highly selective MOFs-based dopamine detection in urine of Parkinson’s patients
Wang et al. Driving force to detect Alzheimer's disease biomarkers: application of a thioflavine T@ Er-MOF ratiometric fluorescent sensor for smart detection of presenilin 1, amyloid β-protein and acetylcholine
Qu et al. Highly selective metal–organic framework-based sensor for protamine through photoinduced electron transfer
Han et al. An amine-functionalized metal-organic framework and triple-helix molecular beacons as a sensing platform for miRNA ratiometric detection
Lu et al. Multiplex detection of nucleases by a graphene-based platform
Zhang et al. Colorimetric detection of bis-phosphorylated peptides using zinc (ii) dipicolylamine-appended gold nanoparticles
Chen et al. MnO2 microsphere absorbing Cy5-labeled single strand DNA probe serving as powerful biosensor for effective detection of mycoplasma ovipneumoniae
Wang et al. Simultaneous detection of multiple exosomal microRNAs for exosome screening based on rolling circle amplification
Zhu et al. Turn-on fluorescent assay based on purification system via magnetic separation for highly sensitive probing of adenosine
CN104749369A (en) Fluorescent labeling method for living organisms having cell membrane structures
Liu et al. Intracellular fluorometric determination of microRNA-21 by using a switch-on nanoprobe composed of carbon nanotubes and gold nanoclusters
Wang et al. Enzyme-embedded ZIF-8/DNA nanocomposite probe for live cells imaging and sensitive detection of ATP

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190201